LOS ANGELES, June 17 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday authorized emergency use of the Moderna and Pfizer-BioNTech COVID-19 vaccines for children down to 6 months of age.
For the Moderna vaccine, the FDA amended the emergency use authorization (EUA) to include use of the vaccine in individuals 6 months through 17 years of age. The vaccine had previously been authorized for use in adults 18 years of age and older.
